Oppenheimer analyst Jay Olson assigned a Buy rating to CymaBay Therapeutics (CBAY) yesterday and set a price target of $14.00.
The post Oppenheimer Thinks CymaBay Therapeutics Stock is Going to Recover appeared first on Smarter Analyst.
Oppenheimer analyst Jay Olson assigned a Buy rating to CymaBay ...

https://www.smarteranalyst.com/new-blurbs/oppenheimer-thinks-cymabay-therapeutics-stock-is-going-to-recover-2/

#SmarterAnalyst